PUBBLICAZIONI SCIENTIFICHE

Rivista:
Cancer Research 59:13-3245:3250, 1999 - I.F. 12,07

7 – Loss of P27Kip1 Expression Correlates with Tumor Grade and with Reduced Disease-free Survival in Primary Superficial Bladder Cancers

AUTORI: Alessandro Sgambato , Mario Migaldi , Beatrice Faraglia , Lorella Garagnani , Gianpiero Romano , Achille Cittadini

p27Kip1 is a member of the Cip1/Kip1 family of cyclin-dependent kinase inhibitors and is a potential tumor suppressor gene. We previously reported a deregulated

LEGGI

Rivista:
International Journal of Cancer 78:1-33.:40, 1998 - I.F. 7,39

6 – N1,N12-bis(ethyl)spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines.

AUTORI: Gaetano Marverti, Giorgio Piccinini, Stefania Ghiaroni, Daniela Barbieri, Daniela Quaglino, Maria Stella Moruzzi

The results presented here demonstrate that a cisdiamminedichloroplatinum(II) (DDP)-resistant human ovarian-carcinoma cell line isalso cross-resistant to the spermine analogue N1 ,N12-bis(ethyl)spermine (BESPM). W e

LEGGI

Rivista:
Journal of Clinical Investigation 101:8-1572:1580, 1998 - I.F. 14,80

5 – Tumorigenic Conversion of p53-deficient Colon Epithelial Cells by an Activated Ki-ras Gene

AUTORI: Cinzia Sevignani, Pawel Wlodarski, Julie Kirillova, W. Edward Mercer, Keith G. Danielson, Bruno Calabretta

Distinct genetic abnormalities (loss-of-function mutations of APC and p53 and oncogenic activation of Ki-ras) are associated with specific stages of the sporadic, most common

LEGGI

Rivista:
Leukemia 10:2-S69:S71, 1996 - I.F. 11,52

4 – High-dose therapy and autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin’s disease responding to first-line therapy. Analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol of EBMT/ANZLG/Intergroup HD01 Trial.

AUTORI: Massimo Federico, Vera Clò, Angelo Michele Carella

Whether high-dose therapy (HDT) plus autologous stem cell transplantation (ASCT) ought to be included in the initial treatment plan for those patients with unfavourable

LEGGI

COME CONTRIBUIRE

FONDAZIONE

7 – Loss of P27Kip1 Expression Correlates with Tumor Grade and with Reduced Disease-free Survival in Primary Superficial Bladder Cancers

6 – N1,N12-bis(ethyl)spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines.

5 – Tumorigenic Conversion of p53-deficient Colon Epithelial Cells by an Activated Ki-ras Gene

4 – High-dose therapy and autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin’s disease responding to first-line therapy. Analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol of EBMT/ANZLG/Intergroup HD01 Trial.

RICERCA SUL CANCRO

PUBBLICAZIONI SCIENTIFICHE

PROGETTI DI RICERCA

BORSE DI STUDIO E STAGE ALL'ESTERO

PREMI DI STUDIO

PREMIO "PIER CAMILLO BECCARIA"